Onkologija impact factor, indexing, ranking (2024)


onkologija

Aim and Scope

The Onkologija is a research journal that publishes research in the field of oncology, neoplasms, radiology, palliative care, drug therapy, neoplasm metastasis. This journal is published by the Institute of Oncology Ljubljana. The ISSN of this journal is 1408-1741.

Also, please check the following important details about onkologija: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.

According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.

The ISSN (International Standard Serial Number) is an 8-digit code used to uniquely identify journals. ISSN numbers are assigned by a network of ISSN National Centres, usually located at national libraries and coordinated by the ISSN International Centre based in Paris. The International Centre is an intergovernmental organization created in 1974 through an agreement between UNESCO and the French government.

Important Metrics

Journal Title: Onkologija
Publisher: Institute of Oncology Ljubljana
P-ISSN: 1408-1741
E-ISSN: 1581-3215
Language: Slovenian
Country of Publisher: Slovenia
APC: No
Processing Time (Weeks): 10
Review Process: Double anonymous peer review
Subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens

onkologija Indexing

The onkologija is indexed in:

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).

Note: ESCI journals donot come with an impact factor. However, ESCI journals are evaluated every year and those who qualified are transferred to SCIE.


Onkologija Impact Factor 2024

The latest impact factor of onkologija is N/A.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times it's articles are cited.

Note: Every year, The Clarivate releases the Journal Citation Report (JCR). The JCR provides information about academic journals including impact factor. The latest JCR was released in June, 2023. The JCR 2024 will be released in the June 2024.


Publication fee

Based on the Official Journal Homepage, the onkologija does not charge any publication fee.

An article processing charge (APC), also known as a publication fee, is a fee which is sometimes charged to authors. Most commonly, it is involved in making a work available as open access (OA), in either a full OA journal or in a hybrid journal.



Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Onkologija?

If your research is related to oncology, neoplasms, radiology, palliative care, drug therapy, neoplasm metastasis, then visit the official website of onkologija and send your manuscript.

Tips for publishing in Onkologija:

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Alternatively, they can contact the editor of the journal.

Journal Publication Time

The Journal Publication Time means the average number of weeks between article submission and publication. According to the journal website, the onkologija publishes research articles in 10 weeks on an average.


Final Summary

  • The impact factor of onkologija is N/A.
  • The onkologija is a reputed research journal.
  • It is published by Institute of Oncology Ljubljana.
  • The journal is indexed in UGC CARE, ESCI, DOAJ.
  • It is an open access journal.
  • The publication time (Average number of weeks between article submission and publication) of the journal is 10 weeks.
  • Based on the Official Journal Homepage, the onkologija does not charge any publication fee.

Sources: https://revijaonkologija.si/







SIMILIAR JOURNALS


ADVANCES IN RADIATION ONCOLOGY

ISSN:
Publisher: ELSEVIER INC

INTERNATIONAL JOURNAL OF PARTICLE THERAPY

ISSN:
Publisher: INT JOURNAL PARTICLE THERAPY

JOURNAL OF BREAST IMAGING

ISSN: 2631-6110
Publisher: OXFORD UNIV PRESS

PHYSICS & IMAGING IN RADIATION ONCOLOGY

ISSN:
Publisher: ELSEVIER

RADIOLOGY-IMAGING CANCER

ISSN: 2638-616X
Publisher: RADIOLOGICAL SOC NORTH AMERICA (RSNA)

REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY

ISSN: 1507-1367
Publisher: VIA MEDICA

BRACHYTHERAPY

ISSN: 1538-4721
Publisher: ELSEVIER SCIENCE INC

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

ISSN: 1084-9785
Publisher: MARY ANN LIEBERT, INC

CANCER IMAGING

ISSN: 1740-5025
Publisher: BMC

CANCER RADIOTHERAPIE

ISSN: 1278-3218
Publisher: ELSEVIER

TOP RESEARCH JOURNALS

Credit and Source: Scopus, Clarivate, UGC CARE.